These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18400610)

  • 1. MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody.
    Chia WT; Chen YW; Cheng LY; Lee HS; Chang DM; Sytwu HK
    J Formos Med Assoc; 2008 Mar; 107(3):245-52. PubMed ID: 18400610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperleptinemia suppresses aggravation of arthritis of collagen-antibody-induced arthritis in mice.
    Okano T; Koike T; Tada M; Sugioka Y; Mamoto K; Inui K; Okihana H; Ebihara K; Nakao K; Nakamura H
    J Orthop Sci; 2015 Nov; 20(6):1106-13. PubMed ID: 26293802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide accelerates collagen-induced arthritis in association with rapid and continuous production of inflammatory mediators and anti-type II collagen antibody.
    Tanaka S; Toki T; Akimoto T; Morishita K
    Microbiol Immunol; 2013 Jun; 57(6):445-54. PubMed ID: 23773023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.
    Hutamekalin P; Saito T; Yamaki K; Mizutani N; Brand DD; Waritani T; Terato K; Yoshino S
    J Immunol Methods; 2009 Mar; 343(1):49-55. PubMed ID: 19330909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells are involved in the development of arthritis induced by anti-type II collagen antibody.
    Mitamura M; Nakano N; Yonekawa T; Shan L; Kaise T; Kobayashi T; Yamashita K; Kikkawa H; Kinoshita M
    Int Immunopharmacol; 2007 Oct; 7(10):1360-8. PubMed ID: 17673151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1beta in irrigation fluid and mRNA expression in synovial tissue of the knee joint as therapeutic markers of inflammation in collagen antibody-induced arthritis.
    Chia WT; Yeh LT; Chen YW; Lee HS; Chang DM; Sytwu HK
    Dis Markers; 2009; 26(1):1-7. PubMed ID: 19242063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
    Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
    Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.
    Lee SW; Kim JH; Park MC; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(4):260-8. PubMed ID: 18612926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
    Shen X; Li C; Zhao H; Li S; Chen J; Kobayashi Y; Shen W
    J Ethnopharmacol; 2011 Mar; 134(2):399-405. PubMed ID: 21215307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model.
    Zhao R; Chen NN; Zhou XW; Miao P; Hu CY; Qian L; Yu QW; Zhang JY; Nie H; Chen XH; Li P; Xu R; Xiao LB; Zhang X; Liu JR; Zhang DQ
    J Transl Med; 2014 Dec; 12():330. PubMed ID: 25491303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II collagen-specific antibodies induce cartilage damage in mice independent of inflammation.
    Croxford AM; Whittingham S; McNaughton D; Nandakumar KS; Holmdahl R; Rowley MJ
    Arthritis Rheum; 2013 Mar; 65(3):650-9. PubMed ID: 23239042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.
    Li Q; Ren G; Xu L; Wang Q; Qi J; Wang W; Zhou B; Han X; Sun C; Wu Q; Yu Y; Peng Z; Zheng S; Li D
    Int Immunopharmacol; 2014 Jul; 21(1):119-27. PubMed ID: 24800661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis.
    Okumura A; Saito T; Otani I; Kojima K; Yamada Y; Ishida-Okawara A; Nakazato K; Asano M; Kanayama K; Iwakura Y; Suzuki K; Yamagoe S
    Arthritis Rheum; 2008 Feb; 58(2):413-21. PubMed ID: 18240267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model.
    Nasu Y; Nishida K; Miyazawa S; Komiyama T; Kadota Y; Abe N; Yoshida A; Hirohata S; Ohtsuka A; Ozaki T
    Osteoarthritis Cartilage; 2008 Jun; 16(6):723-32. PubMed ID: 18226559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
    Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
    Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effect of bee venom on type II collagen-induced arthritis.
    Lee JD; Kim SY; Kim TW; Lee SH; Yang HI; Lee DI; Lee YH
    Am J Chin Med; 2004; 32(3):361-7. PubMed ID: 15344419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.